Anika Therapeutics, Inc. (ANIK)
$20.53+0.29%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $273M
- Beta
- 0.21
- P/E (TTM)
- -76.18
- Short % float
- 2.95%
- Days to cover
- 4.4
- SI change
- -3.7%
- 1W
- +7.37%
- 1M
- -3.11%
- vs SPY 1W
- +6.95%
- vs SPY 1M
- -5.18%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 11
- VALUE
- 5
- GROWTH
- 52
- GARP
- 7
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-1.6%
REV YoY-
ROE-2.7%
EPS YoY-
ROA-2.1%
GROSS62
OP-4
NET-3
[VALUATION]
P/E TTM-76.18
P/E FWD24.46
SECTOR PE20.34
INDUSTRY PE11.11
P/B2.01
P/FCF-
EV/EBITDA95.46
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E16.98
ALTMAN Z-
CURR RATIO4.48
ND/EBITDA-
BETA0.21
Company news
FAQ
- What is LOPJLB’s current signal on ANIK?
- LOPJLB’s latest quantitative signal on Anika Therapeutics, Inc. (ANIK) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ANIK in?
- Anika Therapeutics, Inc. (ANIK) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Anika Therapeutics, Inc. (ANIK) do?
- Anika Therapeutics, Inc. is a company dedicated to joint preservation, innovating and providing early intervention orthopedic care across the globe, including the United States and Europe. Their core focus areas include osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and advanced bone-preserving joint technologies. All of Anika's products are developed, manufact…